glycopeptide

Phleomycin 是在链霉菌中发现的，引起 DNA 切割的抗癌糖肽抗生素之一。 它类似于博来霉素，它结合并插入 DNA 以破坏双螺旋的完整性。

A40926 (Dalbavancin Impurity) 是Dalbavancin 的前体，是一种糖肽抗生素。它抑制革兰氏阳性细菌，对淋病奈瑟氏球菌非常有效。

Sialylglycopeptide 是一种有用的有机化合物，可用于生命科学领域的相关研究。其产品编号为 T64549，CAS号为 189035-43-6。

Bleomycin Sulfate (Blenoxane) 是一种糖肽抗生素，一种 DNA 合成抑制剂。Bleomycin Sulfate 可以引起 DNA 链断裂而不引起 RNA 链断裂。Bleomycin Sulfate 具有抗肿瘤活性。

Vancomycin 是一种糖肽类抗生素，可以通过改变细胞膜的渗透性并选择性地抑制核糖核酸的合成以发挥抗菌活性。Vancomycin 可以用于治疗所有抗生素均无效的严重感染。

SNAP 398299 是一种甘丙肽受体 3 型 （Gal3）拮抗剂，具有抗焦虑和抗抑郁样作用，可用于研究情绪障碍。

Teicoplanin (MDL-507) 是一种半合成的糖肽抗生素, 可用于由革兰氏阳性菌引起的严重感染的相关研究。

Dirithromycin (LY237216) 是一种红霉素衍生物，是一种具有口服活性的半合成大环内酯类抗生素。它用于治疗许多不同类型的细菌感染。

MAC-545496 是一种抗毒剂，可逆转耐甲氧西林的菌株中的 β-内酰胺耐药性。它是糖肽抗性相关蛋白 R 的纳摩尔抑制剂，对全长 GraR 蛋白具有很强的结合亲和力。

ZINC77292789 (Fmoc-Thr[GalNAc(Ac)3-α-D]-OH) 是制备基于三聚体 MUC1 免疫显性基序抗原的候选抗癌疫苗的起始材料，可制备含有 βGalNAc-​Thr 作为 Tn 抗原异构体的合成 MUC1 糖肽，可诱导针对肿瘤细胞的抗体产生。

Parvodicin C2, a glycopeptide antibiotic derived from A. parvosata and part of the parvodicin complex, serves as a component of the A40926 antibiotic complex utilized as a precursor for synthesizing dalbavancin. It exhibits activity against methicillin-sensitive and methicillin-resistant strains of S. aureus, S. epidermidis, S. saprophyticus, S. hemolyticus, and E. faecalis.

Vancomycin-C13,D3 是一种由 13C 和 2H 标记的化合物。Vancomycin 是一种糖肽类抗生素，可以通过改变细胞膜的渗透性并选择性地抑制核糖核酸的合成以发挥抗菌活性。

Teicoplanin aglycone is an antibacterial glycopeptide antibiotic used in the prophylaxis and treatment of serious infections caused by Gram-positive bacteria, including Enterococcus faecalis and methicillin-resistant Staphylococcus aureus.

Chloroorienticin A is an antibiotic in the class of glycopeptide.

Vancomycin monohydrochloride is an amphoteric glycopeptide antibiotic that inhibits bacterial cell wall synthesis by binding to peptidoglycan.

Sephadex G 50 is a gel filtration medium commonly utilized in gel permeation chromatography for effective fractionation of glycopeptide mixtures.

2-Azido-2-deoxy-D-galactose, 98% 可用于糖生物学，可用于糖肽糖基化和合成糖缀合物。

N-Demethylvancomycin is a glycopeptide antibiotic that has been found inNocardia orientalis.1It is active against several strains ofS. aureusandS. epidermidisin vitroandin vivo.2Formulations containing N-demethylvancomycin have been used in the treatment of bacterial infections. 1.Boeck, L.D., Mertz, F.P., Wolter, R.K., et al.N-demethylvancomycin, a novel antibiotic produced by a strain of Nocardia orientalis. Taxonomy and fermentationJ. Antibiot. (Tokyo)37(5)446-453(1984) 2.Hunt, A.H., Marconi, G.G., Elzey, T.K., et al.A51568A: N-demethylvancomycinJ. Antibiot. (Tokyo)37(8)917-919(1984)

Parvodicin complex is a mixture of closely related lipophilic glycopeptides originally isolated from A. parvosata. The parvodicin complex has activity against Gram-positive bacteria (MICs = 0.8-12.5 μg ml) including methicillin-resistant strains of S. aureus (MRSA), S. hemolyticus, and E. faecalis (MICs = 0.1-25 μg ml). Glycopeptide antibiotics act by preventing cell wall synthesis by binding and sequestering a cell wall precursor with a D-alanine-containing peptide.

Phleomycin D1 (PLM D1) 是一种由Streptomyces verticillus(轮枝链霉菌)的突变株产生的一种糖肽抗生素，具有抗菌活性，可破坏细菌双螺旋结构的完整性。Phleomycin D1 可用于筛选携带Sh ble基因的转染细胞。

Bleomycin A5 (Pingyangmycin)，一种具有口服活性的糖肽类抗生素，既是抗肿瘤剂、细胞凋亡诱导剂，又是细菌代谢产物。

N-Demethylvancomycin，一种源自Nocardia orientalis的糖肽类抗生素，对多种金黄色葡萄球菌和表皮葡萄球菌菌株显示出抗菌活性，常被应用于感染相关研究。

Ristocetin A, a glycopeptide related to vancomycin, is an antibiotic produced by the microorganism Nocardia lurida[1]. Ristocetin A is currently in clinical use to treat bacterial infections [1]. Ristocetin A is an antibiotic which can be used to treat staphylococcal infections. The side effects of ristocetin A include thrombocytopenia and platelet agglutination. Ristocetin A has been used in two assays: the ristocetin cofactor assay and the ristocetin-induced platelet aggregation assay. These two assays could be used to diagnosis the von Willebrand disease and other bleeding disorders [2, 3]. The structural features of Ristocetin A are similar to vancomycin.

Lipid II binder 5107930 is a lipid II binder which causes specific upregulation of the vancomycin-resistance associated gene vraX, which is implicated in the cell wall stress stimulon that confers glycopeptide resistance.